Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
In the context of Ertugliflozin + Metformin & Type 2 diabetes (T2D), The US FDA approved the fixed‑dose combination ertugliflozin + metformin as an adjunct to diet and exercise for adults with T2D. Ertugliflozin + Metformin can be used as a stand‑alone FDC or with other antidiabetic agents.
The EMA authorized ertugliflozin + metformin FDC for adults with T2D. Intended to improve glycemic control alongside lifestyle changes and other glucose‑lowering drugs. EMA notes significant HbA1c reduction, weight loss, and blood pressure benefits consistent with the SGLT‑…